TipRanks

Esther Rajavelu Insider Profile

4 Followers
Esther Rajavelu, CEO, CFO and Chief Business Officer at Spero Therapeutics, holds 1.01M shares in Spero Therapeutics (Ticker: SPRO), holds ― shares in Fulcrum Therapeutics (Ticker: FULC). Most recently, Esther Rajavelu Sold ― shares of Spero Therapeutics on May 06, 2026 for an estimated value of $63.35K.
tipranks
Esther Rajavelu

Esther Rajavelu
Spero Therapeutics (SPRO)
CEO, CFO and Chief Business Officer

Ranked #75,554 out of 109,193 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

-10.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
A breakdown of Esther Rajavelu's holdings

Insider Roles

Spero Therapeutics
(SPRO)
CEO, CFO and Chief Business Officer
Fulcrum Therapeutics
(FULC)
CFO
Roles that Esther Rajavelu holds in companies

Most Profitable Insider Trade

Stock:
Spero Therapeutics
(SPRO)
Rating:Informative Sell
Date:Nov 12, 2025 - Today
Return:+53.70%
The most profitable trade made by Esther Rajavelu

Esther Rajavelu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Spero Therapeutics
May 06, 2026
CEO, CFO and Chief Business Officer
Informative Sell
63.35K
$1.28M
Fulcrum Therapeutics
―
CFO
―
―
List of latest transactions for each holding click on a transaction to see Esther Rajavelu's performance on stock

Esther Rajavelu insider profile FAQ

What is the percentage of profitable transactions made by Esther Rajavelu?
The percentage of profitable transactions made by Esther Rajavelu is 67%.
    What is the average return per transaction made by Esther Rajavelu?
    The average return per transaction made by Esther Rajavelu is -10.70%.
      What stocks does Esther Rajavelu hold?
      Esther Rajavelu holds: SPRO, FULC stocks.
        What was Esther Rajavelu’s latest transaction?
        Esther Rajavelu latest transaction was an Informative Sell of $63.35K.
          What was Esther Rajavelu's most profitable transaction?
          Esther Rajavelu’s most profitable transaction was an Informative Sell of SPRO stock on November 12, 2025. The return on the trade was 53.70%.
            What is Esther Rajavelu's role in Spero Therapeutics?
            Esther Rajavelu's role in Spero Therapeutics is CEO, CFO and Chief Business Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.